VitaK-CAC Study: Raising the Standard of Cardiovascular Health with MenaQ7®

Explore the groundbreaking VitaK-CAC Trial, a 2-year study using MenaQ7® recently published in JAMA Cardiology.
This study is the first clinical trial showing the effect of stand-alone Vitamin K2 MK-7 supplementation on the progression of Coronary Artery Calcification (CAC).

Register Free: https://www.nutritionaloutlook.com/no_w/vitak-cac

Event Overview:

Join us for an exclusive 1-hour webinar exploring the groundbreaking VitaK-CAC Trial, a 2-year study using MenaQ7® recently published in JAMA Cardiology;
This study is the first clinical trial showing the effect of stand-alone Vitamin K2 MK-7 supplementation on the progression of Coronary Artery Calcification (CAC).

Coronary artery calcification reflects the “vascular age” of the arteries. It develops early in the pathogenesis of atherosclerosis, driven by an imbalance between mechanisms that promote and inhibit calcium deposition in the vascular wall. Finding effective ways to manage CAC progression is a critical goal for the health supplement industry.

In this session, we will examine how Vitamin K2 as MK-7 supplementation produced nearly one-third less progression of coronary artery calcification, a recognized predictor of cardiovascular disease, compared with placebo.

Key Learning Objectives:

• Hear about unprecedented findings in CAC Agatston score and calcium mass progression
• Recognize the clinical significance of results unseen in previous trials with such low-dose vitamin K or drugs
• Learn about the science behind MenaQ7® benefits, including how it supports healthy calcium balance in coronary arteries

Who Should Attend:

• Brand Owners
• CEOs
• R&D
• Marketing
• Product Developers
• Professionals in Medical Affairs or Regulatory
  

Speakers:

Lacey Hall, MS
Director of Global Medical Affairs
Gnosis by Lesaffre

Lacey Hall, MS, is the Director of Global Medical Affairs at Gnosis by Lesaffre. With a master’s degree in clinical nutrition, her career spans from supporting critically ill patients in the hospital setting, working one-on-one with individuals through nutritional therapy, to leading scientific strategy in the corporate sector. Over the past seven years, she has specialized in advancing research and education on the gut microbiome and therapeutic interventions.

Register Free: https://www.nutritionaloutlook.com/no_w/vitak-cac